Antibacterial Activity and Property of the Fermentation Product of Marine Streptomyces sp. GB-2

Chinese Journal of Biotechnology

Volumn 23, Issue 6, 2007, Pages 1077-1081

  LIU, Shu ^a   LU, Ying Jian ^b   LU, Zhao Xin ^a   LÜ, Feng Xia ^a   BIE, Xiao Mei ^a   FANG, Yao Wei ^a   DING, Zhong Yang ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b NANJING TECH UNIVERSITY   (China)

Author keywords

antibacterial activity; Marine Streptomyces sp. GB 2; stability; the fermentation product

Indexed keywords

ANTIINFECTIVE AGENT; SEA WATER;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; FERMENTATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STREPTOMYCES;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; FERMENTATION; MICROBIAL SENSITIVITY TESTS; SEAWATER; STAPHYLOCOCCUS AUREUS; STREPTOMYCES;

NEGIBACTERIA; POSIBACTERIA; STREPTOMYCES; STREPTOMYCES SP.;

EID: 37049009906     PISSN: 18722075     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1872-2075(07)60066-1     Document Type: Article

References (17)

1. Zou Y., Sun M., and Wang Y. Purification and characterization of a lysozyme from a marine microorganism. Chinese Journal of Biotechnology 21 3 (2005) 420-424
2. Zhang X., Zhao Q., Xue S., et al. Bioactive compounds from marine sponges and cell culture of marine sponges. Chinese Journal of Biotechnology 18 1 (2002) 10-15
3. Bull A. Biodiversity as a source of innovation in biotechnology. Annu Rev Microbiol 46 (1992) 219-252
4. Cho W., Lee H., Rho J., et al. New lactone-containing metabolites from a marine-derived bacterium of the genus Streptomyces. J Nat Prod 64 5 (2001) 664-667
5. Venugopal J., Michael S., Hartmut L., et al. New butenolides from two marine Streptomycetes. J Nat Prod 63 11 (2000) 1570-1572
6. Wang J., Soisson S., Young K., et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441 (2006) 358-361
7. Kin S. Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 9 (2006) 245-251
8. Bradley S., John A., and Xiang L. Exploiting marine actinomycete biosynthetic pathways for drug discovery. Anto Van Leeuwen 87 (2005) 49-57
9. Shen P., Fan X., and Li G. Microbiology Experiment. 3rd ed (1999), Higher Education Press, Beijing 214-222
10. Zheng Z., Zeng W., Huang Y., et al. Detection of antitumor and antimicrobial activities in marine organism associated actinomycetes isolated from the Taiwan Strait, China. FEMS Microbiol Lett 188 (2000) 87-91
11. Zhou D. Handbook of Microbiology Experiment (1980), Shanghai Scientific and Technical Publishers, Shanghai 339
12. Yao H. Veterinary Microbiology Experiment Manual. 2nd ed. (2002), China Agricultural Press, Beijing 43-45
13. Pathirana C., Tapiolas D., Jensen P., et al. Structure determination of maduralide: a new 24-membered ring macrolide glycoside produced by a marine bacterium (Actinomycetales). Tetrahedron Lett 32 (1991) 2323-2326
14. Umezawa H., Okami Y., Kurasawa S., et al. Marinactan, antitumor polysaccharide produced by marine bacteria. J Antibiot 36 4 (1983) 471-477
15. Trischman J., Tapiolas D., Jensen P., et al. Salinamides A and B: anti-inflammatory depsipeptides from a marine Streptomycete. J Am Chem Soc 116 (1994) 757-758
16. Zeng W. Screening of marine actinomycetes with antitumor activity and isolation and identification of the cytotoxic compounds produced by strain N350 (2001), Xiamen University, Xiamen 34
17. Lotfi M., Raoudha B., Samiha S., et al. Isolation, purification and partial characterization of antibacterial activities produced by a newly isolated Streptomyces sp. US24 strain. Res Microbiol 154 (2003) 345-352